권호기사보기
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
결과 내 검색
동의어 포함
| 기사명 | 저자명 | 페이지 | 원문 | 목차 |
|---|---|---|---|---|
| A case of obstructive jaundice caused by tuberculous lymphadenitis: A literature review | Su Jung Baik, Kwon Yoo, Tae Hun Kim, Il Hwan Moon, Min-Sun Cho | pp.208-213 |
|
|
| Pure red-cell aplasia and autoimmune hemolytic anemia in a patient with acute hepatitis A | Hyo Jeong Chang, Dong Hyun Sinn, Sung Gyun Cho, Tae Hoon Oh, Tae Joo Jeon, Won Chang Shin, Won Choong Choi | pp.204-207 |
|
|
| No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients | Nae-Yun Heo, Young-Suk Lim, Woochang Lee, Minkyung Oh, Jiyun An, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Han Chu Lee, Yung Sang Lee, Dong Jin Suh | pp.177-184 |
|
|
| Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus | Hyun Young Woo, Jong Young Choi, Seung Kew Yoon, Dong Jin Suh, Seung Woon Paik, Kwang Hyub Han, Soon Ho Um, Byung Ik Kim, Heon Ju Lee, Mong Cho, Chun Kyon Lee, Dong Joon Kim, Jae Seok Hwang | pp.168-176 |
|
|
| Alcoholic fatty liver disease elevates estimated coronary heart disease risk to levels comparable with those of nonalcoholic fatty liver disease in the Korean population : a cross-sectional study | Hai Jin Kim, Jeong Han Kim, Won Hyeok Choe, So Young Kwon, Chang Hong Lee | pp.154-161 |
|
|
| Changes in the seroprevalence of IgG anti-hepatitis A virus between 2001 and 2013 : experience at a single center in Korea | Sung Jun Chung, Tae Yeob Kim, Sun Min Kim, Min Roh, Mi Yeon Yu, Jung Hoon Lee, ChangKyo Oh, Eun Young Lee, Seung Lee, Yong Cheol Jeon, Kyo-Sang Yoo, Joo Hyun Sohn | pp.162-167 |
|
|
| Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation | Ju-Yeun Lee, Yul Hee Kim, Nam-Joon Yi, Hyang Sook Kim, Hye Suk Lee, Byung Koo Lee, Hyeyoung Kim, Young Rok Choi, Geun Hong, Kwang-Woong Lee, Kyung-Suk Suh | pp.192-203 |
|
|
| Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal | Yun Jung Choi, Jeong Han Kim, Ja Kyung Koo, Cho I Lee, Ji Young Lee, Jae Hoon Yang, Soon Young Ko, Won Hyeok Choe, So Young Kwon, Chang Hong Lee | pp.185-191 |
|
| 번호 | 참고문헌 | 국회도서관 소장유무 |
|---|---|---|
| 1 | REFERENCES 1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-2917. | 미소장 |
| 2 | Recurrent hepatocellular carcinoma after liver transplantation – an emerging clinical challenge ![]() |
미소장 |
| 3 | Liver transplantation in association with hepatocellular carcinoma: An update of the International Tumor Registry ![]() |
미소장 |
| 4 | Low Recurrence Rate of Hepatocellular Carcinoma after Liver Transplantation: Better Patient Selection or Lower Immunosuppression? ![]() |
미소장 |
| 5 | Predictive value of biological markers for hepatocellular carcinoma patients treated with orthotopic liver transplantation. ![]() |
미소장 |
| 6 | Recurrent hepatocellular carcinoma after transplantation: Use of a pathological score on explanted livers to predict recurrence ![]() |
미소장 |
| 7 | Liver Transplantation for Hepatocellular Carcinoma Under Calcineurin Inhibitors: Reassessment of Risk Factors for Tumor Recurrence ![]() |
미소장 |
| 8 | Cyclosporine induces cancer progression by a cell-autonomous mechanism. ![]() |
미소장 |
| 9 | Chen ZS, He F, Zeng FJ, Jiang JP, Du DF, Liu B. Early steroid withdrawal after liver transplantation for hepatocellular carcinoma. World J Gastroenterol 2007;13:5273-5276. | 미소장 |
| 10 | Sirolimus‐based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma ![]() |
미소장 |
| 11 | U.S. Food and Drug Administration (FDA). Rapamune highlights of prescribing information. FDA web site, |
미소장 |
| 12 | Hepatitis B Immunoglobulins Inhibit Dendritic Cells and T Cells and Protect Against Acute Rejection After Liver Transplantation ![]() |
미소장 |
| 13 | Yi NJ, Lee KW, Kong SY, Park KU, Lee KB, Hong G, et al. Outcome of various treatments for posttransplant hepatitis B virus recurrence. World J Surg 2013;37:812-819 | 미소장 |
| 14 | Optimizing use of basiliximab in liver transplantation ![]() |
미소장 |
| 15 | THE ROLE OF 18F-FDG-PET IMAGING FOR THE SELECTION OF LIVER TRANSPLANTATION CANDIDATES FROM AMONG HEPATOCELLULAR CARCINOMA PATIENTS. ![]() |
미소장 |
| 16 | The Role of Liver Transplantation in Hepatobiliary Malignancy. A Retrospective Analysis of 95 Patients with Particular Regard to Tumor Stage and Recurrence ![]() |
미소장 |
| 17 | Current controversies surrounding liver transplantation for hepatocellular carcinoma ![]() |
미소장 |
| 18 | Management of hepatocellular carcinoma ![]() |
미소장 |
| 19 | Prognostic Factors for Tumor Recurrence after a 12-Year, Single-Center Experience of Liver Transplantations in Patients with Hepatocellular Carcinoma ![]() |
미소장 |
| 20 | Recurrence of hepatocellular carcinoma after liver transplant: Patterns and prognosis ![]() |
미소장 |
| 21 | Majno P, Giostra E, Mentha G; Geneva liver cancer study. Is there a customised immunosuppressive regimen for patients transplanted with hepatocellular carcinoma? J Hepatol 2005;43:577-584. | 미소장 |
| 22 | Decaens T, Roudot-Thoraval F, Bresson-Hadni S, Meyer C, Gugenheim J, Durand F, et al. Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patients. World J Gastroenterol 2006;12:7319-7325. | 미소장 |
| 23 | BASILIXIMAB INDUCTION IN ADULT LIVER TRANSPLANT RECIPIENTS WITH 93% REJECTION FREE PATIENT AND GRAFT SURVIVAL AT 24 MONTHS. ![]() |
미소장 |
| 24 | Basiliximab in a Triple-Drug Regimen With Tacrolimus and Steroids in Liver Transplantation ![]() |
미소장 |
| 25 | Basiliximab (Simulect) for the treatment of steroid-resistant rejection in pediatric liver transpland recipients: a preliminary experience1 ![]() |
미소장 |
| 26 | Targeting of CD4+CD25high cells while preserving CD4+CD25low cells with low-dose chimeric anti-CD25 antibody in adoptive immunotherapy of cancer. ![]() |
미소장 |
| 27 | Basiliximab ![]() |
미소장 |
| 28 | Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. ![]() |
미소장 |
| 29 | Circulating AFP mRNA as a Possible Indicator of Hematogenous Spread of HCC Cells: A Possible Association with HBV Infection. ![]() |
미소장 |
| 30 | Liver Transplantation for Advanced Hepatocellular Carcinoma | 소장 |
| 31 | Significance of des-gamma-carboxy prothrombin in selection criteria for living donor liver transplantation for hepatocellular carcinoma. ![]() |
미소장 |
| 32 | The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin. ![]() |
미소장 |
| 33 | Microscopic vascular invasion detected by anti-CD34 immunohistochemistry as a predictor of recurrence of hepatocellular carcinoma after liver transplantation ![]() |
미소장 |
| 34 | Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis ![]() |
미소장 |
| 35 | Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. ![]() |
미소장 |
| 36 | Simplified staging for hepatocellular carcinoma. ![]() |
미소장 |
*표시는 필수 입력사항입니다.
| 전화번호 |
|---|
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
| 번호 | 발행일자 | 권호명 | 제본정보 | 자료실 | 원문 | 신청 페이지 |
|---|
도서위치안내: 정기간행물실(524호) / 서가번호: 국내16
2021년 이전 정기간행물은 온라인 신청(원문 구축 자료는 원문 이용)
우편복사 목록담기를 완료하였습니다.
*표시는 필수 입력사항입니다.
저장 되었습니다.